John Lister

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

Peter McLaughlin, A.J. Grillo-López, Brian K. Link et al. · Journal of Clinical Oncology · 1998 · 2.8K citations

Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases

Thomas J. Walsh, John W. Hiemenz, Nita L. Seibel et al. · Clinical Infectious Diseases · 1998 · 622 citations · Full text

EVIDENCE FOR A LONG PREDIABETIC PERIOD IN TYPE I (INSULIN-DEPENDENT) DIABETES MELLITUS

A N Gorsuch, John Lister, B.M. Dean et al. · The Lancet · 1981 · 481 citations

Metabolic Syndrome, Diabetes Epidemiology, Diabetes +2

Posterior reversible encephalopathy syndrome in infection, sepsis, and shock.

Walter S. Bartynski, J.F. Boardman, Zella R. Zeigler et al. · PubMed · 2007 · 396 citations · Full text

Clinical Significance of Nephrotoxicity in Patients Treated with Amphotericin B for Suspected or Proven Aspergillosis

John R. Wingard, Paul Kubilis, Lily Lee et al. · Clinical Infectious Diseases · 1999 · 360 citations · Full text